# Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis

> **NCT00052962** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Gastrointestinal Neoplasm

## Interventions

- **PROCEDURE:** Cytoreductive surgery
- **PROCEDURE:** Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP)

## Key facts

- **NCT ID:** NCT00052962
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00052962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00052962, "Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00052962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*